Industry Overview: The Medical Technology Industry in Germany

Global demand for innovative medical technology solutions continues to grow as we live longer, healthier lives. "Medical devices made in Germany" make a significant contribution to enhancing patient health care and quality of life around the world. Medical technologies developed in Germany benefit from a world-class research and business environment, with the sector's predominantly small and medium-sized companies enjoying an international reputation as innovators and market leaders. Internationally, the "Made in Germany" seal continues to be held up as a guarantee of quality; nowhere more so than in the medical device sector. In 2012, global demand for German quality saw almost 70 percent of medical technology products being exported to international markets. Domestically, more than 99 percent of the country's 80 million residents are covered by health insurance. Annual health care expenditure in Germany accounts for EUR 294 billion. In addition to expenses reimbursed by health insurance providers, Germans spend an estimated EUR 60 billion for health care out of their own pockets.

With its state-of-the-art infrastructure and its central location in Europe, Germany is also an ideal location for serving surrounding European countries with an additional potential market volume of more than EUR 1,300 billion.

Download from eHealthNews.eu: Industry Overview: The Medical Technology Industry in Germany (.pdf, 2.782 KB).

About Germany Trade & Invest
Germany Trade & Invest is the economic development agency of the Federal Republic of Germany. The organization promotes Germany as a business and technology location and supports companies based in Germany with global market information.

Most Popular Now

Merck and Tencent Announce Collaboration…

Merck, a leading science and technology company, signed a strategic collaboration agreement with Tencent, a leading provider of Internet value added services. The collaboration will primarily focus on increasing public...

Merck Granted U.S. Patent for Novel Comb…

Merck, a leading science and technology company, today announced that it has been granted Patent No. US 10,193,695 by the United States Patent and Trademark Office (USPTO). The patent relates...

The European Health Catapult Program for…

Through dedicated sessions, a group of international top-level investors, key healthcare leaders and industry stakeholders work closely together challenging 40+ ambitious startups to optimize their business plan and strengthen their...

Applications Now Open for Pioneering Dig…

The Yorkshire & Humber AHSN (Academic Health Science Network), in partnership with mHabitat, announces that applications for the 2019 Propel@YH digital health accelerator programme are now open. Propel@YH has been...

Flagship Axe the Fax Trust Rolls out Hyb…

Leeds Teaching Hospitals NHS Trust (LTHT), the organisation at the forefront of the national Axe the Fax campaign, is implementing an electronic fax solution to tackle its last remaining machines...

First EU Citizens Using ePrescriptions i…

The first EU patients can use digital prescriptions issued by their home doctor when visiting a pharmacy in another EU country: Finnish patients are now able to go to a...

Boehringer Ingelheim (Canada) Ltd. and I…

Boehringer Ingelheim (Canada) Ltd. and IBM Canada announced at the Healthcare Information and Management Systems Society (HIMSS) conference in Orlando, Florida, their plans to explore the use of blockchain technology...

Final Report: Provision of a Market Stud…

The aim of the study is to examine the telemedicine market in Europe and to understand the factors that determine its development. The analysis maps telemedicine applications and solutions, and...

Open Access Drug Development Tools Featu…

New open access tools for drug development, obesity, and the environmental impacts of medicines are the focus of a new IMI2 Call for proposals launched today. The total budget of...

The NHS Long Term Plan: Cracking the Da …

Opinion Article by Prof. Michael Thick, Chief Medical Officer, Chief Clinical Information Officer, IMS MAXIMS Reading the NHS Long Term Plan this week, I had a definite sense of déjà vu...

Big Data Approach Shown to be Effective …

Researchers at Rensselaer Polytechnic Institute who developed a blood test to help diagnose autism spectrum disorder have now successfully applied their distinctive big data-based approach to evaluating possible treatments. The...

Highland Marketing Advisory Board Respon…

The first meeting of Highland Marketing's newly expanded advisory board discussed the NHS Long Term Plan and what will be needed to make it a success. Structural change, leadership, investment...